RNVRENERVE LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Aug 2026, 20:38 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 12 Aug 2026, 20:16 | Quarterly Investor Webinar | Presentations | — | 12008, 14014 | |
| 10 Aug 2026, 20:44 | ReNerve Secures Marketing Approval in India | Company Update | MS | 11001 | |
| 6 Aug 2026, 20:06 | ReNerve Secures Marketing Approval in the Philippines | Company Update | MS | 11001 | |
| 3 Aug 2026, 21:17 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 29 July 2026, 19:24 | Q4 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 14 July 2026, 00:01 | Notification regarding unquoted securities - RNV | Other | — | 06021 | |
| 9 July 2026, 19:14 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 9 July 2026, 19:05 | ReNerve Secures up to A$5 Million Funding Facility | Capital Raising | MS | 03022, 06009 | |
| 6 July 2026, 20:11 | ReNerve Secures Marketing Approval in Indonesia | Company Update | MS | 11001 | |
| 16 June 2026, 19:02 | Notification of cessation of securities - RNV | Other | — | 06027 | |
| 16 June 2026, 19:01 | Clarification of Key Terms STC Distribution Agreement | Company Update | — | 11001 | |
| 11 June 2026, 19:47 | ReNerve appoints J4 as second Empliq manufacturing partner | Company Update | MS | 11001 | |
| 5 June 2026, 19:15 | ReNerve appoints distribution partner for Malaysian Market | Company Update | MS | 11001 | |
| 1 June 2026, 19:44 | New distribution agreement for broader Hong Kong market | Company Update | MS | 11001 | |
| 8 May 2026, 20:02 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 1 May 2026, 21:00 | Quarterly Investor Webinar | Presentations | — | 14014 | |
| 1 May 2026, 19:11 | Notification of cessation of securities - RNV | Other | — | 06027 | |
| 30 Apr 2026, 19:53 | Final Director's Interest Notice - D Rhodes | Director Interests | — | 02010 | |
| 30 Apr 2026, 19:50 | Q3 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 15 Apr 2026, 19:45 | Nerve Guide Matrix Enters Stage 3 of Commercial Development | Company Update | MS | 11001 | |
| 31 Mar 2026, 20:31 | Notification of cessation of securities - RNV | Other | — | 06027 | |
| 24 Mar 2026, 22:47 | Cleansing Notice | Securities Administration | — | 06018 | |
| 24 Mar 2026, 22:46 | Application for quotation of securities - RNV | Other | — | 06020 | |
| 24 Mar 2026, 19:47 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 17 Mar 2026, 21:38 | Half Year Investor Presentation | Presentations | — | 03026 | |
| 10 Mar 2026, 19:42 | Half Year Investor Webinar | Presentations | — | 03027, 14014 | |
| 26 Feb 2026, 21:49 | 1HFY26 Results Announcement | Financial Results | MS | 03004, 03014 | |
| 26 Feb 2026, 21:48 | 1HFY26 Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 19:17 | Cleansing notice | Securities Administration | — | 06018 | |
| 18 Feb 2026, 19:17 | Application for quotation of securities - RNV | Other | — | 06020 | |
| 17 Feb 2026, 20:48 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 16 Feb 2026, 20:33 | ReNerve Receives $517k R&D Refund | Periodic Reports | — | 03014 | |
| 30 Jan 2026, 21:27 | Q2 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 15 Jan 2026, 20:17 | ReNerve receives approval in Malaysia | Company Update | MS | 11001 | |
| 15 Jan 2026, 19:51 | Notification regarding unquoted securities - RNV | Other | — | 06021 | |
| 15 Jan 2026, 19:48 | Cleansing notice | Securities Administration | — | 06018 | |
| 15 Jan 2026, 19:46 | Application for quotation of securities - RNV | Other | — | 06020 | |
| 12 Jan 2026, 20:20 | Broader approval received in Hong Kong for Nerve Cuff | Company Update | MS | 11001 | |
| 5 Jan 2026, 21:23 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 19 Dec 2025, 21:59 | Maja McGuire appointed as Chair | Other | — | 12017 | |
| 13 Dec 2025, 01:11 | Notification of cessation of securities - RNV | Other | — | 06027 | |
| 8 Dec 2025, 23:37 | Additional information on the DoD & VA agreement | Company Update | — | 11001 | |
| 4 Dec 2025, 19:37 | Final Director's Interest Notice - M Panaccio | Director Interests | — | 02010 | |
| 4 Dec 2025, 19:36 | Final Director's Interest Notice - S Cooper | Director Interests | — | 02010 | |
| 4 Dec 2025, 19:34 | Initial Director's Interest Notice - P Savage | Director Interests | — | 02008 | |
| 4 Dec 2025, 19:33 | Initial Director's Interest Notice - M McGuire | Director Interests | — | 02008 | |
| 4 Dec 2025, 19:33 | ReNerve announces Board changes | Company Administration | — | 12001, 12017 | |
| 3 Dec 2025, 19:28 | Correction to Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 2 Dec 2025, 19:28 | Change of Director's Interest Notice - D Rhodes | Director Interests | — | 02009 |
1–50 of 86
1 / 2